Re-shaping gene editing drug design by leveraging nature’s own operating system- the epigenome, and the 3-D spatial organization of the genome to develop effective, safer and reliable therapeutics for patients with high unmet need.
Re-shaping gene editing drug design by leveraging nature’s own operating system- the epigenome, and the 3-D spatial organization of the genome to develop effective, safer and reliable therapeutics for patients with high unmet need.
Avoiding unwanted editing in non-target cells and tissues for higher safety of in vivo editing
Comprehensive short term and long-term impact estimation of editing on the genome and cell functioning
Proprietary target identification, rational gene editing drug design to suit multiple editing nucleases
Reshaping gene editing by leveraging nature’s own operating system-epigenome and the 3-D spatial organization of the genome to develop effective, safe and reliable therapies to provide cures to genetic conditions.
Platform enables target cell & tissue specific editing for high specifity
Technology applicable across all targets and tissues types
Bioinformatics to assess edit impact on genome, epigenome & long-term safety
